The present invention provides novel co-crystal forms of dapagliflozin, namely a dapagliflozin lactose co-crystal and a dapagliflozin asparagine co-crystal, to pharmaceutical compositions comprising same, methods for their preparation and uses thereof for treating type 2 diabetes. A first signal is generated for transmission to the wireless node. Data including resource availability information for each resource used in the manufacturing process, material availability information for each material used in the manufacturing process, and work order information is received and stored in a computer. The invention described can be produced from glass, plastic, steel, aluminum, or other materials suitable for the purposes of this invention or, more generally, for the production of canisters andor canister segments of this type.